An interventional study of 7-day Infusion set replacement and 4-day infusion set replacement in Intensive Care (ICU), Central Venous Catheter Related Infections and Critical Care Nursing, sponsored by University Hospital, Angers. Recruiting at 27 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-13.
Sponsored by University Hospital, Angers · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Catheter-Related Infections with a site in France — 4 open to participants now, 4 under way, none of them phase 3. Catheter-Related Infections · France.
Among the 16 studies in Catheter-Related Infections with a site in France, this one has the largest planned enrollment of the 10 interventional ones that give a count, is one of 4 that started in 2026, is one of 7 with no phase, and was the 13th registered.
113 studies on the registry are indexed under Catheter-Related Infections; 19 are open to participants now.
Browse Catheter-Related Infections studies →4 of the 16 studies in Catheter-Related Infections with a site in France are open now. Recruiting first, the newest first:
Centre Hospitalier Universitaire de Nice · Sites in France
Ages 18+
Centre Hospitalier Universitaire de Nīmes · Sites in France
Ages 18+
Hôpital NOVO · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 10 Catheter-Related Infections studies recruiting now, 9 (90%) set no upper age limit and 1 (10%) stops at 75 or younger; 1 takes children under 18; 1 takes healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 4 started in 2026.
This study's planned enrollment of 2,830 is above the median of 149 across 84 interventional studies indexed under Catheter-Related Infections.
Median enrollment 300 across the 10 interventional studies, 200 across the 6 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 16 have an industry lead sponsor. The 10 most frequent:
University Hospital, Angers is the lead sponsor of 481 studies on the registry; 122 are open to participants now.
University Hospital, Angers has 2 studies filed under Catheter-Related Infections — fewer than ten, so there is no comparison to draw.
2 of the studies in Catheter-Related Infections with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07258862Hôpital NOVOAnalysis of Microbial Biofilms in Peripheral Venous Catheters and Their Implication in Infectious Risk | 2027-03-28 |
| NCT07388381Centre Hospitalier Universitaire de NiceSuperficial Vein Thrombosis of the Upper Limb in Bacteremia Associated With PICCline and Midline Catheters: Frequency and Clinical Consequences | 2027-10-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 16 studies in Catheter-Related Infections with a site in France, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
In the intensive care unit, patients' care and secure drugs administration require a central venous catheter. These invasive devices can lead to complications, particularly infections. Most preventive recommendations focus on catheter insertion, line handling, and dressings. Few recommendations adress catheter dwell time, which is certainly the main source of infection. Part of the prevention strategy is the regular and systematic replacement of infusion sets , as they may become contaminated during use, mainly through the hands of healthcare professionals. Prolonged use increases the risk of infection. Infusion lines changes involve disconnecting the old sets, discarding infusion devices containing drug residues, and replacing them with new sterile devices.
Current international guidelines recommend replacing these sets every 4 days, and the Center for Disease Control and Prevention recommends not exceeding 7 days. Replacing these devices requires the time of qualified nurses, numerous sterile medical devices, and medications. In addition to the intended effect on infection prevention, the procedure has impacts on workload and costs.
The objective of the study is to demonstrate that changing infusion set every 7 days does not increase the rate of central venous catheters related infections compared with changing infusion set every 4 days.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria
Patient whose condition, according to the clinician, does not allow safe placement of a central venous catheter, such as:
Infusion sets connected to the central venous catheter will be replaced every 7 days.
Procedure: 7-day Infusion set replacement
Infusion sets connected to the central venous catheter will be replaced every 4 days.
Procedure: 4-day infusion set replacement
7-day infusion set replacement (Experimental arm) In this group, the infusion sets (the tubes and connectors used to deliver medications through the central venous catheter) will be changed once a week, every 7 days. During each replacement, all sets will be disconnected and replaced with new sterile ones.
4-day infusion set replacement (Active comparator arm) In this group, the infusion sets will be changed every 4 days, which reflects the most common international recommendation. The procedure is the same: all sets connected to the central venous catheter will be replaced with new sterile ones. This strategy represents the current standard of care and will serve as the comparison for the 7-day approach.
Rate (%) of patients with with a central venous catheter-related infectious complication
Infectious complications include: 1. Catheter-related infections (CRI) defined as: * A positive catheter culture, with quantitative culture ≥10³ CFU/ml (Brun-Buisson technique) or, if not available, a semi-quantitative culture \>15 CFU (Maki technique), and purulence at the catheter insertion site or tunnelitis. Or * A positive catheter culture, with quantitative culture ≥10³ CFU/ml (or semi-quantitative culture \>15 CFU), and complete or partial regression of systemic signs of infection within 48 hours after catheter removal. 2. Catheter-related bloodstream infections (bacteremia or fungemia) defined as: * The occurrence of bacteremia (or fungemia) within 48 hours before or after catheter removal (or suspected catheter-related infection if the catheter is not immediately removed), And * Either a positive culture with the same microorganism from the insertion site or catheter, with ≥10³ CFU/ml (Brun-Buisson technique) or, if not available, a semi-quantitative culture
Time frame: From central venous catheter insertion until 48 hours after catheter removal during the ICU stay (censored at 90 days).
Central line-associated bloodstream infection (CLABSI)
Proportion of patients with central line-associated bloodstream infection
Time frame: Day 90
Non-central line-associated bloodstream infection
Proportion of patients with non-central line-associated bloodstream infection
Time frame: Day 90
Catheters with catheter colonization
Proportion of catheters with catheter colonization
Time frame: From central venous catheter insertion until 48 hours after catheter removal during the ICU stay (censored at 90 days).
Time to onset of central venous catheter-related infectious complication
Length of time (in days) before the onset of central venous catheter-related infectious complications
Time frame: Day 90
ICU length of stay
Length of ICU stay
Time frame: Day 90
All-cause ICU mortality
Number of patients who die from any cause during their ICU stay
Time frame: Day 90
Cumulative nursing time related to infusion set replacements
Total nursing time, measured in minutes, required to perform infusion set replacements, per 1000 catheter-days
Time frame: 1000 days
Cost of materials required for infusion set replacements
Cost (euros) of materials required for infusion set replacements, per 1000 cathéter days
Time frame: 1000 days
Plan to share: Undecided
No publications or documents are linked to this record.
Started May 2026 (actual). Primary completion is estimated for May 2028, 24 months after the start.
Of 28 non-industry interventional studies with no phase under Catheter-Related Infections, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 36. This study's planned 24 months is close to that.
Counting every sponsor, half of 31 studies reached it within 22 months; a quarter within 13 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.